John N. Colgan

Hematology | Oncology

4800 Sand Point Way NE
Seattle, WA 98105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.

Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.

Journal: Blood advances

Published: December 08, 2025

Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

Journal: Blood advances

Published: December 08, 2025

The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.

The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.

Journal: British journal of haematology

Published: August 14, 2025

Showing 1-3 of 3

Last Updated: 09/26/2026